What's new in Interventional Cardiology

Designed By & For you, PCRonline offers a wealth of constantly updated information on interventional cardiovascular medicine. Whether you’re looking for the latest articles, cases, course presentations or videos, check out these pages regularly, or better yet, sign up for our newsletter and remain in the know!

Filter By

91 results

PCR: Collaborative, inclusive and global

15 Nov 2025 – From PCR London Valves 2025

At PCR, collaboration and inclusion are at the heart of everything we do.

Together, we create an environment where expertise is shared, talents complement each other, and diversity becomes a strength. It is this collective spirit that drives interventional cardiology forward and inspires innovation every day.

During PCR London...

PCR: Collaborative, inclusive and global

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2025

17 Nov 2025

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

Selection of top Late-breaking Trials presented at #PCRLV

MITRACURE: From results to next steps

Edoardo Zancanaro interviews Julien Dreyfus & David Messika-Zeitoun about the MITRACURE registry, a large international initiative aimed at capturing real-world data on patients with mitral regurgitation referred for surgery. in 2019. The study shows outcomes differ from expert centers, with higher mortality and lower repair rates, especially...

MITRACURE: From results to next steps

The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study

03 Nov 2025

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sofia Papadopoulou

Author

Sofia Papadopoulou
INVEST-CTO: Single arm study of a planned investment procedure in high-risk CTO PCI

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Trish Singh

Author

Trish Singh
PROCTOR: PCI of native coronary artery vs SVGin patients with prior CABG

iFR versus angiography-guided CABG: 3-year results of the iCABG randomised trial

31 Oct 2025

Alex Sticchi provides his take on the iCABG trial presented by Rasa Ordiene at TCT 2025, in San Francisco.

Alessandro Sticchi

Author

Alessandro Sticchi
iFR versus angiography-guided CABG: 3-year results of the iCABG randomized trial

Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

31 Oct 2025

Nicola Ryan provides her take on the PROMISE trial presented by Rocco Antonio Montone at TCT 2025, in San Francisco.

Nicola Ryan

Author

Nicola Ryan
Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

OCT insights of thrombus extraction by stent-retriever thrombectomy (SRT) and manual aspiration (MA): Insights from RETRIEVE AMI trial

29 Oct 2025

Aaysha Cader provides her take on sub-analyses of the RETRIEVE AMI trial presented by Jason Leo Walsh at TCT 2025, in San Francisco.

Author

Aaysha Cader
RETRIEVE AMI: OCT insights of SRT and MA

1-year SELUTION DeNovo results: what they mean for daily practice

29 Oct 2025

The SELUTION DeNovo trial, presented by Christian Spaulding at TCT 2025, delivers the first head-to-head comparison between a sirolimus DCB strategy and contemporary DES in PCI.

In this review, Salvatore Brugaletta breaks down the 1-year results and what these findings truly mean for everyday lesion-by-lesion decision-making.

Guillaume Bonnet

Author

Guillaume Bonnet

Author

Christian Spaulding

Author

Salvatore Brugaletta
1-year SELUTION DeNovo results: what they mean for daily practice

Comparison of drug-coated versus conventional balloons for treatment of side branches of bifurcation lesions: the OCVC-BIF study

29 Oct 2025

Ali Nazmi Calik provides his take on the OCVC-BIF study presented by Takayuki Ishihara at TCT 2025, in San Francisco.

Author

Ali Nazmi Calik
Comparison of drug-coated versus conventional balloons for treatment of side branches of bifurcation lesions: The OCVC-BIF study